SCHEMBL19910481

SCHEMBL19910481

CN(Cc1ccccc1F)Cc1ccc(C(=O)O)cc1F

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.62
ALDH1A1 P00352 1/20 0.62
LTA4H P09960 1/20 0.53
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
ATM Q13315 2/20 0.51
TAS2R14 Q9NYV8 2/20 0.49
ACHE P22303 2/20 0.48
RAB9A P51151 1/20 0.47
GAA P10253 1/20 0.47
RIPK1 Q13546 1/20 0.46
POLB P06746 1/20 0.45
HCAR3 P49019 1/20 0.45
EPHX2 P34913 1/20 0.45
NR1H4 Q96RI1 1/20 0.45
LPAR1 Q92633 2/20 0.44
LPAR5 Q9H1C0 2/20 0.44
HDAC4 P56524 2/20 0.44
HDAC7 Q8WUI4 2/20 0.44
HDAC11 Q96DB2 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11828345 0.83 RXRA (0.53) KDM4EATMTAS2R14RAB9AEPHX2
SCHEMBL19910455 0.81 L3MBTL1 (0.50) KDM4EALDH1A1LTA4HMEN1KMT2A
SCHEMBL19910376 0.79 ALDH1A1 (0.48) KDM4EALDH1A1LTA4HMEN1KMT2A
SCHEMBL19910374 0.77 KDM4E (0.46) KDM4EALDH1A1LTA4HMEN1KMT2A
SCHEMBL19910479 0.76 LPAR1 (0.55) KDM4EALDH1A1LTA4HMEN1KMT2A
SCHEMBL19910426 0.76 GAA (0.59) KDM4EALDH1A1LTA4HMEN1KMT2A
SCHEMBL4124943 0.76 EPHX2 (0.55) KDM4EALDH1A1MEN1KMT2ARAB9A
SCHEMBL19868556 0.75 TAS2R14 (0.40) KDM4EALDH1A1LTA4HMEN1KMT2A
Hydrochloric Acid SCHEMBL29137808 0.73 ALDH1A1 (0.59) KDM4EALDH1A1MEN1KMT2AATM
Hydrochloric Acid SCHEMBL29690748 0.73 ALDH1A1 (0.59) KDM4EALDH1A1MEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3065738-B1 COMPOSITIONS AND METHODS FOR MODULATING FARNESOID X RECEPTORS NOVARTIS AG (CH) 2018-02-28 EP disclosed